Next, we evaluated the effects of inhibiting the phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway on Id1 and integrin α4 in EPCs of patients with ovarian cancer. The gene discussed is AKT1; the disease is ovarian carcinoma.